Pediatric chemo regimen cuts mortality in ALL patients under 40

04/23/2012 |

Israeli researchers reported in the American Journal of Hematology that teens and young adults with acute lymphoblastic leukemia who were given pediatric-inspired induction chemotherapy drugs had lower all-cause mortality and relapse rates than the group receiving traditional adult chemotherapy regimens. They also found that the pediatric-inspired chemotherapy group had greater remission and event-free survival rates compared with the other group.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX